Thursday, December 2, 2021

FDA Commission Considers Pfizer’s COVID Vaccine For US Children

The FDA’s Independent Advisory Committee will meet on Tuesday to consider issuing an emergency authorization for the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11.

While young children become seriously ill or die from COVID-19 is considered rare, but FDA vaccine chief Dr. Peter Marks told the panel on Tuesday that 1.9 million children in the 5-11 age group have tested positive. and 8,300 were hospitalized. United States. A third of those hospitalized required intensive care and nearly 100 died.

Officials hope that if the childhood dose of the vaccine is approved as expected, it will help close a major gap in the US vaccination campaign that has worried parents, educators and public health officials.

Last week, the White House said it had already received enough vaccine for all 28 million children in the United States who would be eligible to be vaccinated, and created a network of pediatricians, pharmacies and other health care providers to quickly roll out vaccinations.

Pending FDA approval, an independent advisory committee from the Centers for Disease Control and Prevention is expected to consider the proposal next week.

Read Also:  How are red-blue lightning made? | Leader

Moderna vaccine

US pharmaceutical company Moderna said clinical trials show low dose COVID-19 vaccine is safe for children ages 6 to 11.

The company says it vaccinated more than 4,700 children with its two-dose vaccine, approximately 28 days apart, with each vaccine being roughly half that of adults. Preliminary results show that antibody levels in children were at the same level as in young adults who received the full dose.

Moderna says the children suffered from mild side effects such as fatigue, headache, fever, and pain at the injection site. The number of subjects was too small to detect any rare side effects such as myocarditis, an inflammation of the heart, which was found mainly in boys and young adults who received the Moderna or Pfizer vaccine.

The study has not been published by any peer-reviewed journal, but Moderna says it will soon present its findings to the FDA and other global drug regulatory bodies.

Some of the information for this report came from the Associated Press and Reuters.

Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -